Optimizing the role of FDG PET–CT for potentially operable metastatic colorectal cancer

被引：0
|
作者：
A. D. Culverwell
F. U. Chowdhury
A. F. Scarsbrook
机构：
[1] Leeds Teaching Hospitals NHS Trust,Departments of Clinical Radiology and Nuclear Medicine
[2] St James’s University Hospital,Department of Nuclear Medicine
来源：
Abdominal Imaging | 2012年 / 37卷
关键词：
Colonic carcinoma; Rectal carcinoma; Fluorine fluorodeoxyglucose; Positron emission tomography–computed tomography; Metastatic disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Recent treatment advances now allow a realistic chance of cure in selected patients with metastatic colorectal carcinoma (CRC). Accurate pre-treatment staging is crucial to ensure appropriate management by identification of patients with more advanced disease who will not benefit from surgery. 18Fluorine 2-fluoro-2-deoxy-d-glucose positron emission tomography–computed tomography (PET–CT) has a firmly established role in staging, restaging, and recurrence detection of a range of tumors. This article will review the role of PET–CT in patients with CRC with a particular emphasis on optimizing the technique in patients with potentially operable metastatic disease.
引用
收藏
页码：1021 / 1031
页数：10
相关论文
共 50 条
  • [41] The role of FDG PET (CT) for diagnosis of peritoneal carcinomatosis of colorectal origin
    Liberale, G.
    Lecocq, C.
    Garcia, C.
    Muylle, K.
    Covas, A.
    Andry, G.
    El Nakadi, I.
    Flamen, P.
    EJC SUPPLEMENTS, 2009, 7 (02): : 169 - 169
  • [42] Recurrent and metastatic breast cancer PET, PET/CT, PET/MRI: FDG and new biomarkers
    Gaeta, C. M.
    Vercher-Conejero, J. L.
    Sher, A. C.
    Kohan, A.
    Rubbert, C.
    Avril, N.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 57 (04): : 352 - 366
  • [43] Role of FDG-PET Staging in Selecting the Optimum Patient for Hepatic Resection of Metastatic Colorectal Cancer
    Strasberg, Steven M.
    Dehdashti, Farrokh
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 102 (08) : 955 - 959
  • [44] rtificial intelligence applications on restaging [18F]FDG PET/CT images of metastatic colorectal cancer
    Alongi, Pierpaolo
    Comelli, Albert
    Stefano, Alessandro
    Spataro, Alessandro
    Formica, Giuseppe
    Laudicella, Riccardo
    Lanzafame, Helena
    Panasiti, Francesco
    Longo, Costanza
    Midiri, Federico
    La Grutta, Ludovico
    Burger, Irene A.
    Bartolotta, Tommaso
    Baldari, Sergio
    Lagalla, Roberto
    Midiri, Massimo
    Russo, Giorgio
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [45] Quantitative Parameters of 18F-FDG PET/CT as a biomarker of KRAS expression in Metastatic Colorectal Cancer
    Moustafa, S.
    Khallaf, S.
    Rayan, A.
    Tawakol, A.
    Makawy, M.
    Mostafa, N. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S527 - S527
  • [46] Relationship Between 18F-FDG PET/CT Scans and KRAS Mutations in Metastatic Colorectal Cancer
    Kawada, Kenji
    Toda, Kosuke
    Nakamoto, Yuji
    Iwamoto, Masayoshi
    Hatano, Etsuro
    Chen, Fengshi
    Hasegawa, Suguru
    Togashi, Kaori
    Date, Hiroshi
    Uemoto, Shinji
    Sakai, Yoshiharu
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (09) : 1322 - 1327
  • [47] Comparison study of FDG-PET and CT/MRI for metastatic liver lesions from colorectal cancer.
    Liu, FM
    Lacorte, LB
    Neto, CAP
    Zhuang, HM
    Alavi, A
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 308P - 308P
  • [48] ASSESSING TUMOR RESPONSE TO CHEMOTHERAPY IN PEDIATRIC METASTATIC COLORECTAL CANCER: THE USE OF CEA AND FDG-PET/CT
    Drezner, Nicole
    Doros, Leslie
    Rossi, Chris
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S82 - S82
  • [49] Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy
    Hendlisz, A.
    Golfinopoulos, V.
    Garcia, C.
    Covas, A.
    Emonts, P.
    Ameye, L.
    Paesmans, M.
    Deleporte, A.
    Machiels, G.
    Toussaint, E.
    Vanderlinden, B.
    Awada, A.
    Piccart, M.
    Flamen, P.
    ANNALS OF ONCOLOGY, 2012, 23 (07) : 1687 - 1693
  • [50] Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy
    Hendlisz, A.
    Golfinopoulos, V.
    Garcia, C.
    Emonts, P.
    Covas, A.
    Ameye, L.
    Paesmans, M.
    Deleporte, A.
    Machiels, G.
    Toussaint, E.
    Vanderlinden, B.
    Awada, A.
    Piccart, M.
    Flamen, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345